| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/03/2011 | CN102140473A Anti-tumor nucleic acid and polypeptide and application thereof |
| 08/03/2011 | CN102140130A Antibacterial peptide and use thereof |
| 08/03/2011 | CN102139114A Polymer factor VIII moiety conjugates |
| 08/03/2011 | CN102139099A Therapeutic composition with a botulinum neurotoxin |
| 08/03/2011 | CN102139098A Lysozyme-rich novel biological synergist |
| 08/03/2011 | CN102139097A Pharmaceutical composition for treating cancers and preparation method thereof |
| 08/03/2011 | CN102139096A Injectable biological active factor composition and preparation method and application thereof |
| 08/03/2011 | CN102139095A Method for applying neuregulin to prevent, treat or delay cardiac ischemia reperfusion injuries, and composition for preventing, treating or delaying cardiac ischemia reperfusion injuries |
| 08/03/2011 | CN102139094A Application of long-chain neurotoxin of cobra in preparation of muscarine type M4 receptor activator |
| 08/03/2011 | CN102139093A Application of short-chain cobrotoxin in preparation of intrathecally administrated analgesic medicines |
| 08/03/2011 | CN102139092A Leech freeze-dried powder injection solution for injection and preparation method thereof |
| 08/03/2011 | CN102138909A Asparaginase freeze-dried powder injection and preparation method thereof, as well as asparaginase solution |
| 08/03/2011 | CN102138908A Thymopentin lyophilization powder injection for injection and preparation process thereof |
| 08/03/2011 | CN102138905A RhBMP-2-loaded chitosan microspheres, preparation method thereof and application thereof |
| 08/03/2011 | CN101797304B Gel for adjusting microecology in vaginas of women |
| 08/03/2011 | CN101716214B Medical composition containing dandelion extract as well as novel application and preparation method thereof |
| 08/03/2011 | CN101618207B Application of polypeptide in preparing ACE inhibitor and medicine for lowering blood pressure |
| 08/03/2011 | CN101550181B Human papilloma virus 16 type E7 protein functional antagonist peptide and encoding gene and application thereof |
| 08/03/2011 | CN101519436B Cyclic octapeptide compound in Hsisha sponge and application thereof |
| 08/03/2011 | CN101361968B Use of interleukin-22 in treating fatty liver |
| 08/03/2011 | CN101307346B Method for extracting brain strengthening bioactive peptide from brain tissue of farming animals |
| 08/03/2011 | CN101275126B Purified high-specific-activity recombinant batroxobin |
| 08/03/2011 | CN101244255B Thymus gland pentapeptide injection and uses thereof |
| 08/03/2011 | CN101147801B Application of dexoyribozyme of target EBV-LMP1 in preparing medicine for treating EBV corresponding solid tumor |
| 08/03/2011 | CN101054418B Fusion polypeptide and application thereof in preparing scald medicament |
| 08/02/2011 | US7989612 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 08/02/2011 | US7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/02/2011 | US7989590 Peptides that increase collagen or hyaluronic acid production |
| 08/02/2011 | US7989589 Compstatin analogs with improved activity |
| 08/02/2011 | US7989587 SSX-2 peptides presented by HLA class II molecules |
| 08/02/2011 | US7989585 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 08/02/2011 | US7989489 Synergistic mixtures |
| 08/02/2011 | US7989486 In combination with epidermal growth factor receptor tyrosine kinase inhibitors; apoptosis of infected cells; suppressing formation of post infectious chronic inflammatory conditions; human and veterinary medicine |
| 08/02/2011 | US7989434 Heterocyclic self-immolative linkers and conjugates |
| 08/02/2011 | US7989427 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 08/02/2011 | US7989426 Selective induction of apoptosis to treat ocular disease by expression of PEDF |
| 08/02/2011 | US7989420 Smooth muscle relaxation |
| 08/02/2011 | US7989419 Insulin composition |
| 08/02/2011 | US7989418 Methods for the use of branched chain amino acids |
| 08/02/2011 | US7989417 Linkers for radiopharmaceutical compounds |
| 08/02/2011 | US7989416 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. Liguriae |
| 08/02/2011 | US7989415 Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome |
| 08/02/2011 | US7989414 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 08/02/2011 | US7989216 Two helix binders |
| 08/02/2011 | US7989208 Gamma secretase notch biomarkers |
| 08/02/2011 | US7989192 Modified beta-lactamase and method for its preparation |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7988979 Neisseria meningitidis antigens and compositions |
| 08/02/2011 | US7988975 Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies |
| 08/02/2011 | US7988974 comprise a macromolecular carrier group fused to a gp41-derived DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LA1 gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 08/02/2011 | US7988973 Activin-ActRII antagonists and uses for increasing red blood cell levels |
| 08/02/2011 | US7988972 Immunoreactive peptides from Epstein-Barr virus |
| 08/02/2011 | US7988969 Treatment for central nervous system disorders |
| 08/02/2011 | US7988965 Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim |
| 08/02/2011 | US7988964 NOGO-a neutralising immunoglobulin for treatment of neurological diseases |
| 08/02/2011 | US7988957 Histone deacetylase inhibitor; adeno-associated virus vector; gene therapy; packages |
| 08/02/2011 | CA2625806C Compositions for improving skin conditions comprising human growth hormone as an active ingredient |
| 08/02/2011 | CA2566776C Method for ameliorating an inflammatory skin condition |
| 08/02/2011 | CA2523859C Methods and devices for the sustained release of multiple drugs |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2484604C .delta. 4,5 glycuronidase and uses thereof |
| 08/02/2011 | CA2475395C Anti-human tenascin monoclonal antibody |
| 08/02/2011 | CA2458325C Nutritional composition for controlling blood sugar level |
| 08/02/2011 | CA2457218C Process for purifying glycopeptide phosphonate derivatives |
| 08/02/2011 | CA2450318C Improved methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 08/02/2011 | CA2449634C Somatostatin-dopamine chimeric analogs |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2441690C Method for the identification of antigenic peptides |
| 08/02/2011 | CA2436623C Branched polyalkylene glycols |
| 08/02/2011 | CA2423999C Compositions and medical devices utilizing bioabsorbable liquid polymers |
| 08/02/2011 | CA2419285C New uses for amino acid anticonvulsants |
| 08/02/2011 | CA2418976C Skin wound healing promoters |
| 08/02/2011 | CA2417984C Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 08/02/2011 | CA2412650C Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 08/02/2011 | CA2412012C Resorbable extracellular matrix containing collagen i and collagen ii for reconstruction of cartilage |
| 08/02/2011 | CA2407309C Dna sequences encoding dystrophin minigenes and methods of use thereof |
| 08/02/2011 | CA2370187C Treatment of neoplasms with viruses |
| 08/02/2011 | CA2368824C Rapid dehydration of proteins |
| 08/02/2011 | CA2349038C Methods of alleviating cancer symptoms |
| 08/02/2011 | CA2329683C Iga nephropathy-related dna |
| 08/02/2011 | CA2328418C Use of lipopeptides or lipoproteins for wound treatment |
| 08/02/2011 | CA2323757C Antibody variants and fragments thereof |
| 08/02/2011 | CA2321169C Modified enzymes and their use for peptide synthesis |
| 08/02/2011 | CA2320220C Isolated dna or gene responsible for parkinson's disease |
| 08/02/2011 | CA2219275C Therapeutic agent and treatment for canine intractable dermatitis |
| 08/02/2011 | CA2107569C Parathyroid hormone receptor and dna encoding same |
| 08/02/2011 | CA1341619C Recombinant inhibin |
| 07/28/2011 | WO2011091419A2 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery |
| 07/28/2011 | WO2011091401A2 Treatment of immune disorders using kainate receptor antagonists |
| 07/28/2011 | WO2011091357A1 Aromatic-cationic peptides and uses of same |
| 07/28/2011 | WO2011091344A1 Pan-antiviral peptides for protein kinase inhibition |
| 07/28/2011 | WO2011091304A1 Delivery system for diagnostic and therapeutic agents |
| 07/28/2011 | WO2011091244A1 Methods to treat or prevent a skin condition using a nell1 peptide |
| 07/28/2011 | WO2011091167A2 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 07/28/2011 | WO2011091027A2 Recombinant live attenuated foot-and-mouth disease (fmd) vaccine containing mutations in the l protein coding region |
| 07/28/2011 | WO2011091000A2 Oral care compositions and methods |
| 07/28/2011 | WO2011090971A2 Osteocalcin as a treatment for male reproductive disorders |
| 07/28/2011 | WO2011090947A2 Methods for the diagnosis and treatment of parkinson's disease |
| 07/28/2011 | WO2011090306A2 Liquid formulations for long-acting erythropoietin conjugate |
| 07/28/2011 | WO2011090270A2 Composition containing osmotin for preventing and treating neurological disorders |